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Tet methylcytosine dioxygenase 2 (Tet2) is an epigenetic regulator
that removes methyl groups from deoxycytosine residues in DNA.
Tet2-deficient murine macrophages show increased lipopolysac-
charide (LPS)-induced and spontaneous inflammation at least
partially because Tet2 acts to restrain interleukin (IL)-1β and IL-6
expression in induced cells. MicroRNAs have emerged as critical
regulatory noncoding RNAs that tune immune cell responses to
physiological perturbations and play roles in pathological condi-
tions in macrophages. To determine if a microRNA played any role
in Tet2 activity, we examined the interrelationship of Tet2 action
and the let-7 microRNA family, utilizing several let-7 microRNA
engineered murine models. We first showed that Tet2, but not
Tet3, is a direct target of the let-7a-1/let-7d/let-7f-1 (let-7adf)
microRNAs in macrophages. We found that overexpression or de-
letion of the let-7adf gene cluster causes altered IL-6 induction
both in tissue culture cells induced by LPS treatment in vitro as
well as in a Salmonella infection mouse model in vivo. Mechanis-
tically, let-7adf promotes IL-6 by directly repressing Tet2 levels and
indirectly by enhancing a Tet2 suppressor, the key TCA cycle me-
tabolite, succinate. We found that Let-7adf promotes succinate
accumulation by regulating the Lin28a/Sdha axis. We thereby
identify two pathways of let-7 control of Tet2 and, in turn, of
the key inflammatory cytokine, IL-6, thus characterizing a regula-
tory pathway in which a microRNA acts as a feedback inhibitor of
inflammatory processes.
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Enzymes that act on epigenetic processes regulate the func-tioning of immune cells. Targeting of these enzymes has been
proven to be a valuable tool to dampen inflammatory responses
(1, 2). Tet2 is one of the earliest and most frequently mutated
genes in myeloid neoplasms, including myelodysplastic syndrome
and chronic myelomonocytic leukemia (3). Inactivating muta-
tions in Tet2 can cause epigenetic dysregulation and monocytic
lineage skewing (4, 5). Loss of Tet2 results in the up-regulation
of interleukin (IL)-6 following a challenge with lipopolysaccha-
ride (LPS) and an increase of IL-1β expression in macrophages
(6, 7). Tet2-deficient mice are highly susceptible to dextran
sulfate-induced colitis, with a more severe inflammatory phe-
notype and increased IL-6 production compared with WT con-
trol mice (6). However, there may be mechanisms of regulation
of immunity and inflammation by Tet2 independent of its clas-
sical well-known role in modulating DNA demethylation.
MicroRNAs (miRs) are short noncoding RNAs of ∼22 nt that
are involved in the complex posttranscriptional regulatory net-
works that control cellular functions such as inflammation and
metabolism (8, 9). MiR let-7 clusters have been identified as an
important contributor to many physiological and pathological
processes, for instance, tumorigenesis and B cell antibody pro-
duction (10–12). However, the role of miRs in regulating Tet gene
expression remains unclear. Intriguingly, it has been recently
reported that succinate, a TCA cycle intermediate, can inhibit
Tet2 (13–16). IL-6 is a key mediator of inflammation. What re-
mains obscure is the regulatory mechanisms that link succinate to
the alteration of IL-6 levels in inflamed macrophages. Identifying
whether and how a let-7 cluster might be involved in regulating IL-
6 in macrophage inflammatory responses would add significantly
to our understanding of inflammatory processes.
We herein report that the miR-let-7a/let-7d/let-7f cluster (let-
7adf) is involved in promoting IL-6 by regulating Tet2 through
two distinct mechanisms. We demonstrate that let-7adf contrib-
utes to LPS-driven metabolic reprogramming by activating both
glycolysis and succinate accumulation, the latter a consequence of
its ability to significantly reduce the amount of succinate dehy-
drogenase subunit A (Sdha) in activated cells by targeting Lin28a.
We found that let-7adf enhances IL-6 in macrophages by repres-
sing the expression of Tet2, and it also promotes IL-6 levels by
increasing succinate accumulation through regulating the Lin28a/
Sdha axis in LPS-activated macrophages.
Results
Tet2, but Not Tet3, Is a Direct Target of the Let-7adf Cluster in LPS-
Activated Macrophages. We found that both Tet2 and Tet3 were
predicted to be potential targets of let-7d (Fig. 1A, only Tet2 3′
UTR shown) by using computational prediction programs (17).
To investigate if TET proteins might be regulated by let-7 in
LPS-activated macrophages, we first examined TET protein and
mRNA levels in bone marrow-derived macrophages (BMDMs)
derived from let-7adf knockout (KO) and WT control mice. We
found a significant increase in the TET2 protein level in the
absence of let-7adf, compared with WT control BMDMs (Fig.
1B), while the expression of TET1 and TET3 were comparable
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between KO and WT BMDMs, implying that Tet2 might be an
authentic target of let-7adf in macrophages (Fig. 1B). To in-
vestigate whether overexpression of let-7adf in macrophages has
the opposite effect, we generated let-7adf myeloid-cell specific
overexpression transgenic mice (denoted as let-7adf iTg mice).
We observed a decrease of TET2 protein expression in the let-
7adf iTg BMDMs compared with WT control BMDMs but again
saw comparable levels of TET1 and TET3 protein (SI Appendix,
Fig. S1). These results imply that let-7adf selectively inhibits
TET2 protein expression in LPS-activated macrophages.
To further examine the direct effects of let-7adf on Tet2, we
measured the mRNA level in LPS-activated let-7adf–deficient
macrophages. We found that the Tet2 mRNA level was higher in
the let-7adf KO BMDMs compared with WT BMDMs (Fig. 1C),
while BMDMs overexpressing let-7adf displayed a decreased
level of Tet2 mRNA, compared with WT BMDMs (Fig. 1D),
confirming that let-7adf represses Tet2 mRNA in LPS-activated
macrophages. Tet1 and Tet3 were unaffected (SI Appendix, Figs.
S2 A and B and S3 A and B). To further confirm that let-7adf
directly targets Tet2, we engineered a luciferase gene with let-7–
binding sites in its 3′-UTR and observed a significantly decreased
luciferase activity when overexpressing let-7d via a let-7d mimic
(Fig. 1E).
Collectively, these results demonstrate that Tet2 is an au-
thentic target of let-7adf in LPS-activated macrophages, sug-
gesting that let-7adf might promote IL-6 secretion by LPS-
activated macrophages through repressing Tet2.
Let-7adf Is a Physiological Activator of IL-6 Production in Macrophages.
To examine whether the let-7adf cluster regulates IL-6 pro-
duction, we used LPS to activate cultured BMDMs derived from
mice harboring a deletion of the let-7adf cluster and compared
these cells to WT BMDMs. The IL-6 mRNA level following a 24-h
stimulation with LPS was reduced by 50% in the absence of the
Fig. 1. Tet2 is a target of the let-7adf cluster in LPS-activated macrophages. (A) Schematic of the predicted let-7d binding site in the Tet2 3′UTR. (B) The
protein expression of Tet1, Tet2, and Tet3 in BMDMs from WT or the let-7adf cluster KO mice obtained by Western blot. (C) RT-qPCR of the Tet2 mRNA level
in WT control or the let-7adf cluster KO BMDMs. (D) RT-qPCR of Tet2 in WT control or the let-7adf cluster iTg BMDMs. (E) Tet2 3′UTR luciferase reporter assays
in HEK293T cells. **P < 0.01, *P < 0.05, using a Student’s t test.
Fig. 2. Let-7adf is physiologically essential for IL-6 production in macrophages. (A and C) The let-7adf cluster KO/WT BMDMs were stimulated with LPS for
24 h. The IL-6 mRNA level was examined by qPCR (A); ELISAs were performed to examine the production of IL-6 in the cell culture supernatants of the let-7adf
cluster KO/WT macrophages (C). (B and D) The let-7adf cluster iTg/WT BMDMs were stimulated with LPS for 24 h. The IL-6 mRNA level was examined by qPCR
(B); ELISAs were performed to examine the productions of IL-6 in the cell culture supernatants of the let-7adf cluster iTg/WT BMDMs (D), and the BMDMs not
treated with LPS served as controls (Ctrl). (E) The let-7adf cluster KO and WT mice were i.p. infected with sublethal dose of Salmonella and the IL-6 production
in serum was assessed at 24 hpi. Each symbol represents one animal. ****P < 0.0001, ***P < 0.001, **P < 0.01, *P < 0.05, using a Student’s t test.





















miR cluster (Fig. 2A). As expected, we observed the converse
result with cells overproducing let-7adf: These cells displayed in-
creased IL-6 mRNA following 24 h of LPS treatment (Fig. 2B).
Similarly, IL-6 protein levels were decreased by deletion of let-
7adf and were increased by overexpression of let-7adf (Fig. 2 C
and D). These results demonstrate that let-7adf promotes IL-6
mRNA and protein production in activated macrophages in vitro.
To investigate the in vivo physiological consequences of ma-
nipulating let-7adf, we turned to a Salmonella bacterial infection
model. When let-7adf KO and WT control mice were challenged
with a sublethal dose of Salmonella, the let-7adf KO mice dis-
played significantly lower titers of IL-6 in their sera, compared
with control WT mice, as evidenced by ELISA (Fig. 2E). Thus,
let-7adf action contributes to IL-6 production against Salmonella
infection in vivo.
It is evident that let-7adf is an important activator of macro-
phage IL-6 levels in vitro and in vivo.
Let-7adf Promotes IL-6 Through Repressing Tet2. To examine
whether Tet2 is the mediator of the effects of let-7adf on IL-6
production, we asked whether deletion of Tet2 in macrophages
had the opposite effect on IL-6 of deleting let-7adf. In fact, we
observed that the absence of Tet2 led to a heightened IL-6
mRNA and protein production in LPS-activated macrophages
in vitro (Fig. 3 A and B). Tet2 KO mice also showed consistent
results, with higher IL-6 production in sera following LPS
treatment compared with WT mice (Fig. 3C). These results in-
dicate that loss of Tet2 mirrors the effect of let-7adf in macro-
phages on the regulation of IL-6.
To directly investigate whether Tet2 was involved in let-7adf–
mediated IL-6 induction, an siRNA against Tet2 was utilized (SI
Appendix, Fig. S4). We found that this siRNA, but not a
scrambled version, could restore IL-6 mRNA and protein levels
to normal levels, overriding the effects of let-7adf deletion (Fig. 3
D and E). Levels of IL-6 mRNA were significantly restored in
the presence of siRNA-Tet2 compared with scrambled siRNA-
treated let-7adf KO macrophages (Fig. 3D). The let-7adf KO
macrophages transfected with scrambled siRNA did not show
altered levels of mRNA expression for IL-6 compared with no
treatment control (Fig. 3D). Consistently, we found that treat-
ment of these cells with an siRNA-targeting Tet2 strongly res-
cued the impairment of LPS-induced IL-6 production by the
absence of the miR cluster. We observed no IL-6 production
without LPS treatment (Fig. 3E). In addition, Tet2 has been
implicated in the late resolution phase of inflammation (6), so we
examined the expression of Tet2/IL-6 over a time course to
determine whether the regulation by let-7adf cluster is more
widely modulating inflammation in activated macrophages. We
found that IL-6 was lower expressed in let-7adf KO macrophages
over the time course (SI Appendix, Fig. S5). The let-7adf KO
macrophages showed higher Tet2 compared with WT controls at
4 h and 12 h (SI Appendix, Fig. S6). Next, we further asked
whether the Let-7adf–mediated Tet2 regulation mode exists in
other IL-6 inflammatory responses. We utilized another typical
stimuli including TNFa, and we observed similar regulation
pattern (SI Appendix, Fig. S7), indicating that the let-7adf–
mediated Tet2 regulation mode also exists in TNFa-induced
IL-6 inflammatory responses in macrophages.
Thus, it appears that the action of let-7adf on IL-6 is a con-
sequence of the effect of let-7adf on Tet2, confirming that let-
7adf promotes IL-6 expression through targeting Tet2 in LPS-
activated macrophages.
Let-7adf Promotes Succinate Accumulation by Regulating Lin28a/
Sdha Axis in Macrophages. We next sought to examine the meta-
bolic consequences of let-7adf deletion in LPS-activated macro-
phages, examining first its possible role in LPS-induced glycolysis.
BMDMs were treated with LPS, and the extracellular acidification
rate (ECAR) was monitored (Fig. 4A). Let-7adf KO BMDMs
showed a 50% lower extracellular acidification rate compared with
WT BMDMs (Fig. 4A). Knowing that let-7adf contributes to LPS-
driven glycolysis in LPS-activated macrophages, we tested whether
let-7adf influenced mitochondrial function by measuring oxygen
consumption rates (OCR). Remarkably, let-7adf KO BMDMs
showed an even greater OCR curve than WT cells after LPS
treatment (Fig. 4B), implying that let-7adf limits LPS-induced
mitochondrial respiration in WT cells.
In agreement with a role for let-7adf in LPS action, let-7adf
deficiency dramatically reduced LPS-induced succinate accu-
mulation (Fig. 4C), indicating that let-7adf promotes glycolysis as
well as the accumulation of succinate in LPS-activated WT
macrophages. By contrast, we observed a higher ECAR and
succinate level, as well as a lower OCR curve in the let-7adf iTg
BMDMs, compared with WT BMDMs (Fig. 4 D–F), further
confirming the role of let-7adf in enhancing glycolysis and pro-
moting succinate accumulation in LPS-activated macrophages.
To examine the pathway by which let-7adf controlled succinate
accumulation within macrophages, we examined its effect on
succinate dehydrogenase subunit A (Sdha), an enzyme important
for succinate accumulation. SDHA expression in LPS-treated
BMDMs was further enhanced by let-7adf KO and decreased
in let-7adf iTg BMDMs (Fig. 4G), compared with WT controls,
Fig. 3. Let-7adf promotes IL-6 by targeting Tet2. (A and B) The Tet2 KO/WT BMDMs were stimulated with LPS for 24 h. The IL-6 mRNA level was examined by
qPCR (A); IL-6 production was examined by ELISA (B). (C) The TET2 KO and WT mice were injected with LPS (from Salmonella), and the IL-6 production in
serum was assessed at 24 h after innoculation. (D and E) The BMDMs from let-7adf KO, WT, and KO treated with siRNA against Tet2 were stimulated with LPS
for 24 h. The IL-6 mRNA level was examined by qPCR (D); the production of IL-6 in the cell culture supernatants of the Tet2 KO/WT BMDMs was examined by
ELISA (E). ns, not significant; NT, no treatment; ****P < 0.0001, ***P < 0.001, **P < 0.01, *P < 0.05, using a Student’s t test.
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suggesting that let-7adf inhibits SDHA protein expression in
LPS-activated macrophages. We also tested whether let-7adf
affected succinate transport by regulating SLC25A10, a key
succinate transporter, but we found that SLC25A10 expression
was comparable in let-7adf KO and WT control as well as in let-
7adf iTg and control BMDMs (Fig. 4G).
To further test whether SDHA was involved in let-7adf–
mediated succinate accumulation, an siRNA against SDHA
was utilized. Treatment with this siRNA led to increased succi-
nate accumulation in both KO and WT macrophages, which
were now indistinguishable (Fig. 4H). Thus, our data indicate
that SDHA works downstream of let-7adf and controls the suc-
cinate accumulation in macrophages.
To further investigate the molecular pathway directly con-
necting let-7adf to succinate accumulation mediated by Sdha, we
explored the expression of lin28a, which is a well-established
direct target of let-7 (18, 19). We found the lin28a mRNA ex-
pression was enhanced in let-7adf KO macrophages compared
with WT control (Fig. 4I). We next utilized the engineered
mouse model we had generated, which specifically overexpresses
lin28a (denoted as Lin28a iTg mice) in macrophages about 20-
fold (Fig. 4J). We found SDHA protein expression was higher in
Fig. 4. Let-7adf promotes succinate accumulation by regulating the Lin28a/Sdha axis in macrophages. (A) The let-7adf KO/WT BMDMs were examined after
24 h culture following the LPS stimulation, and ECAR was determined by extracellular flux analysis. The representative plot of ECAR over time of macrophages
with addition of glucose (10 mM), oligomycin (1 μM), and 2-DG (20 μM), as indicated. (B) The let-7adf cluster KO/WT macrophages were examined after 24-h
culture following with LPS stimulation, and OCR was determined by extracellular flux analysis. Representative plot of OCR over time with addition of
oligomycin (1 uM), mitochondrial uncoupler FCCP (0.5 μM), and electron transport inhibitors antimycin (1.5 μM) + rotenone (0.75 μM), as indicated. (C) Fold
change of succinate accumulation in the LPS-activated let-7adf KO/WT BMDMs. (D) The let-7adf iTg/WT BMDMs were examined after 24-h culture following
the LPS stimulation, and ECAR was determined by extracellular flux analysis. The representative plot of ECAR over time of macrophages with addition of
glucose (10 mM), oligomycin (1 μM), and 2-DG (20 μM), as indicated. (E) The let-7adf cluster iTg/WT macrophages were examined after 24-h culture following
with LPS stimulation, and OCR was determined by extracellular flux analysis. Representative plot of OCR over time with addition of oligomycin (1 μM),
mitochondrial uncoupler FCCP (0.5 μM), and electron transport inhibitors antimycin (1.5 μM) + rotenone (0.75 μM), as indicated. (F) Fold change of succinate
level in the LPS-activated let-7adf iTg/WT BMDMs. (G) The SDHA and SLC25A10 protein expressions in LPS-activated macrophages from the let-7adf KO/WT
mice as well as the let-7adf iTg/WT mice obtained by Western blot. (H) Fold change of succinate level. Indicated siRNA-SDHA or siRNA control treated LPS-
activated macrophages from let-7adf KO and WT mice were measured. (I) The Lin28a mRNA levels were analyzed by RT-qPCR in let-7adf KO/WT BMDMs. (J)
The Lin28a mRNA levels were analyzed by RT-qPCR in Lin28a iTg/WT BMDMs. (K) The SDHA protein expressions in LPS-activated macrophages from the Lin28a
iTg/WT mice obtained by Western blot. (L) Fold change of succinate level in the LPS-activated Lin28a iTg/WT BMDMs. (M) The Sdha mRNA levels were an-
alyzed by RT-qPCR in LPS-activated let-7adf iTg, let-7adf/lin28a DiTg, and WT BMDMs. ***P < 0.001, **P < 0.01, *P < 0.05, using a Student’s t test.





















lin28a iTg macrophages, suggesting lin28a can also bind and
enhance the accumulation of Sdha in macrophages (Fig. 4K),
which is consistent with a previous report (20). Moreover, we ob-
served a decreased succinate level in lin28a iTg macrophages,
compared with a WT control (Fig. 4L), indicating that lin28a is
one of the direct targets of let-7adf in inhibiting Sdha accumulation
and enhancing succinate levels in LPS-stimulated macrophages.
To further validate whether lin28a mediates the effects of let-
7adf in regulating Sdha in macrophages, we next utilized another
engineered mouse model we had generated, which specifically
overexpresses lin28a in let-7adf iTg mice (denoted as Let-7adf/
Lin28a DiTg mice). We observed that let-7adf/lin28a DiTg
macrophages showed enhanced Sdha expression, compared with
the let-7adf iTg macrophages, suggesting that Lin28a over-
expression partially rescued the altered Sdha expression regu-
lated by let-7adf iTg (Fig. 4M).
Succinate Contributes to Another Regulatory Layer of Let-7adf on
Tet2 and Promotes IL-6. Succinate, a proinflammatory metabo-
lite, accumulates during LPS-induced macrophage activation,
causing an increase in at least one proinflammatory cytokine, IL-
1β (21, 22). Moreover, it has been reported that succinate can
inhibit 2-oxoglutarate–dependent dioxygenases, including TET
proteins (13, 14), raising the question of whether let-7adf regu-
lates Tet2 through modulating succinate accumulation. In addi-
tion, our work has shown that let-7adf promotes succinate
accumulation in macrophages by inhibiting SDHA, prompting us
to examine the effects of succinate in LPS-activated macro-
phages. Using pretreatment of cells with the cell-permeable
compound diethyl succinate, which increases succinate in the
cytosol and mitochondrial matrix (22), we found that diethyl
succinate significantly reduced the increased Tet2 level in let-
7adf KO macrophages (Fig. 5A). This suggests that let-7adf
acts both directly on Tet2 mRNA and indirectly through the
accumulation of succinate to mediate Tet2 repression. Consis-
tent with this notion, the decreased IL-6 mRNA and protein
production in the let-7adf KO BMDMs were also overridden by
addition of diethyl succinate (Fig. 5 B and C). Tet2 KO macro-
phages showed mildly changed levels of succinate accumulation
(SI Appendix, Fig. S8), indicating that Tet2 is not essential to
succinate production in LPS-activated macrophages.
Discussion
This study provides evidence of posttranscriptional regulation of
Tet2 gene expression by the let-7adf miR cluster in LPS-
activated macrophages. Tet2, but not Tet3, is a direct target of
the let-7adf cluster. By inhibiting Tet2 production, the miR
cluster potentiates IL-6 production in macrophages. Another
consequence of the action of the let-7adf cluster on Tet2 is po-
tentiation of succinate production, and succinate also promotes
IL-6 activation. Our results imply a model (Fig. 6) by which the
let-7adf cluster in LPS-activated macrophages regulates Tet2
through two pathways, one a direct effect on Tet2 mRNA and
the other an indirect consequence of succinate regulation. Pre-
sumably, the effects on Tet2 levels caused by let-7adf and suc-
cinate cause alterations in DNA methylation, the only known
effect of Tet2 (23, 24). Perhaps they occur at specific sites, but
the specificity of Tet2 is ill-defined. How methylation alteration
might lead to effects on cytokine gene transcription remains
speculative.
Recently, endogenous metabolites including itaconate and
succinate have emerged as key regulators of macrophage func-
tion, but their precise regulatory mechanism of action remains
unclear. Succinate is clearly another key signaling molecule in
innate immune cells (25, 26). Our current work links succinate to
proinflammatory cytokine IL-6 secretion in LPS-activated mac-
rophages. It will be important to know how succinate is trans-
ported and accumulates in activated macrophages, so that it
triggers inflammation and innate immunity. Moreover, other key
metabolites, such as α-ketoglutarate (α-KG), may contribute to
Fig. 5. Succinate contributes to another regulatory layer of let-7adf on Tet2 and promotes IL-6. (A–C) The let-7adf cluster KO, WT, and KO+ diethyl succinate
(pretreated for 2 h with 5 mM diethyl succinate) BMDMs were stimulated with LPS for 24 h. The Tet2 mRNA level was examined by qPCR (A); the IL6 mRNA
level was examined by qPCR (B); the ELISAs were performed to examine the productions of IL-6 in the cell culture supernatants the let-7adf cluster KO, WT,
and KO+ diethyl succinate BMDMs (C). ****P < 0.0001, **P < 0.01, *P < 0.05, using a Student’s t test.
Fig. 6. The graphical abstract of dual mechanisms of Tet2 regulation by let-
7adf in macrophages. The schematic diagram of the effects of let-7adf
cluster on regulating Tet2 via two distinct mechanisms in macrophages: (i)
through directly targeting Tet2; and (ii) via promoting succinate accumula-
tion by regulating the Lin28a/Sdha axis.
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Tet2 regulation in activated macrophages, because Tet2 utilizes
α-KG as a substrate to hydroxylate 5mc to 5hmc during DNA
demethylation (4). 2-Hydroxyglutarate (2-HG), which is pro-
duced by malfunction of isocitrate dehydrogenase (IDH) 1 or 2,
competitively inhibits the function of α-KG–dependent enzymes
such as Tet2 (27). Thus, to regulate Tet2 through targeting IDH
may be another potential way to potentiate certain macrophage
inflammatory responses. Interestingly, Idh2 gene has a putative
binding site for let-7 in its 3′UTR. It is possible that let-7adf
might target Idh2 in activated macrophages, resulting in an-
other layer of regulation of Tet2, in turn, altering IL-6. IL-6 is a
versatile regulator of physiology and pathological diseases (28,
29), and proper IL-6 expression is strictly controlled by post-
transcriptional regulation (30–32). Our findings imply that
modulation of succinate accumulation through variation of the
let-7adf miR in activated macrophages could play a role in
controlling IL-6. Our current study significantly added this miR
let-7 cluster to one of the contributors that enhance IL-6 level
in vivo. Our results suggest that the let-7adf cluster is an im-
portant inflammatory regulator of LPS-induced innate immune
response in macrophages.
Materials and Methods
Mice. Tet2 KO and LysM Cre mice were purchased from The Jackson Labo-
ratory. Lin28a LysM iTg and Let-7adf cluster LysM iTgmice were generated by
crossing Lin28a iTg and Let-7adf iTg, with LysM-Cre, respectively. Let-7adf/
Lin28a LysM DiTg mice were generated by crossing Lin28a iTg, Let-7adf
iTg, and LysM-Cre mice. All of the mice were housed in the animal facility
of California Institute of Technology. All of the animal procedures were
carried out in accordance with Institutional Animal Care and Use Committee
guidelines of California Institute of Technology.
Bacteria Strain and Infections. Bacteria used in this study were Salmonella
typhimurium SL-1344 strain (Salmonella). Bacteria were grown to mid-
logarithmic phase, pelleted, washed three times using PBS, and stored at
−80 °C in small aliquots until use. The concentration of Salmonella was de-
termined according to a standard growth curve based on the measurements
of absorbance at 600 nm. In vivo Salmonella infections: 6–12 wk mice were
infected intraperitoneally (i.p) with Salmonella SL-1344 strain. Sera were
collected 24 h after Salmonella infections.
ELISAs Assay. ELISAs were performed according to manufacturers’ instruc-
tions. Supernatants derived from the cultures of untreated or LPS-activated
BMDMs were analyzed for IL-6 level with kits from eBioscience and carried
out according to the manufacturer’s instructions.
Statistical Analysis. All statistical analysis was done in GraphPad Prism soft-
ware using an unpaired Student’s t test. Data were reported as mean ± SEM.
Significance measurements were marked as follows: *P < 0.05, **P < 0.01,
***P < 0.001, ****P < 0.0001, or ns for not significant.
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